Focus Stocks
Merck in a very Tight Range
Published on Thursday, 09 September 2010 04:32 Written by TradersHuddle Staff
New York, September 9th (TradersHuddle.com) - Shares of Merck & Co. Inc. (NYSE:MRK) closed the trading session at $35.81 placing the price action in a very tight range, given that calculated support is set at $34.41 and the calculated resistance based on an algorithm of peaks and troughs is set at $35.84
Merck & Co., Inc. (NYSE:MRK), the global pharmaceutical company that develops, manufactures, and markets a broad range of human and animal health products. Merck's products include Zocor for treatment of elevated cholesterol, Propecia for treatment for male pattern hair loss, Fosamax for preventive treatment of osteoporosis, and Singulair for treatment of asthma. Merck was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
Merck's stock price action indicates that both sellers and buyers are materializing very close to each other, which is indicative to a momentum building area, as the stock can resolve by breaking out of the tight range that developed.
Traders wanting to establish a position should place close attention to Merck's price action, as any movement outside its predefined range of $34.41 and $35.84 could grab the attention of momentum buyers, looking for a big movement in the price of the stock. Traders need to be aware that tight range resolution works both ways, hence, a move below support at $34.41 could spark above average selling. A tiered approach can be a good way to approach starting a position in Merck's, by establishing a starter position while the stock is in the tight range, and then adding to the position as it breaks and closes above resistance.
Related Articles
- Thomas E. Shenk To Retire From Merck's Board of Directors
- Merck Announces Top-Line Results of TRA-2P Study of Vorapaxar
- Merck Provides Update on Development Program for Suvorexant, an Investigational Orexin Receptor Antagonist for the Treatment of Insomnia
- Approaching Resistance - Merck
- Bank of America - Top Performing Dow Component
- Research Analyst's Up/Downgrades ( APKT, BRCD, CVC, KMX, HVB, LINTA, AGP, MRK, IP )
- Bears Appeared - Merck
- FDA Approves JANUMET® XR (sitagliptin and metformin HCl extended-release) for Type 2 Diabetes, Offering the Powerful Efficacy of JANUMET® (sitagliptin/metformin HCl) Now Available with Once-Daily Convenience
- Dow's Top Performers :AA, BAC, AXP
- Stocks Tread Water on Mixed Earnings and Bernanke Testimony
Related Partner Headlines
- Merck Announces Top-Line Results of TRA-2P Study of Vorapaxar - Benzinga
- Merck Confirms Plans to File NDA for Suvorexant in 2012 - Benzinga
- FDA Approves JANUMET XR for Type 2 Diabetes - Benzinga
- Dow Today: Merck (MRK) Lower - TheStreet.com
- Merck, Pfizer: Dow Midday Movers - TheStreet.com
- UPDATE: Merck Swings To Q4 Profit - Benzinga
- Merck's Earnings Are Up, But a Huge Drop may be Coming - Benzinga
- Merck Beats, Expects Flat 2012 Adjusted EPS - TheStreet.com
- Dow Today: Merck (MRK) Leads The Day Higher, Travelers Companies (TRV) Lags - TheStreet.com
- Merck Stock Hits New 52-Week High (MRK) - TheStreet.com
TradersHuddle Search
Recent Trading Ideas
Latest Partner Headlines
-
Benzinga's Microcap Movers for Wednesday February 8, 2012 - Benzinga -
Five More Stocks ETFs Need More Of - Benzinga -
ETFs to Watch February 9, 2012 - Benzinga -
'Fast Money' Recap: Cisco's Back - TheStreet.com -
Benzinga's M&A Chatter for Wednesday February 8, 2012 - Benzinga -
Market Preview: Fearing the Inevitable Pullback - TheStreet.com -
Mike Khouw's OpenTable Inc Trade - Benzinga -
Fast Money Picks For February 9th - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,883.95 Trade time:4:02PM EST Value change:▲5.75 (0.04%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,349.96 Trade time:4:31PM EST Value change:▲2.91 (0.22%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,915.86 Trade time:5:16PM EST Value change:▲11.78 (0.41%)In The Wires
-
gategroup Seeks to Extend and Amend Credit Facilities -
Publicis Groupe: 2011 Annual Results -
VIDEO from Siemens and Synaptic Digital: US Transportation Secretary LaHood to Visit Siemens Light Rail Manufacturing Plant in Sacramento -
Comstock Mining Announces Pricing of Public Offering of Common Stock -
Boeing 787 Dreamliner Debuts in Bangkok for Dream Tour -
SYNC Accelerates into 2013 as Standard Equipment on New Ford Fusion and Flex -
Bacteria Detection Time Cut From Days to Minutes -
Pantone Announces Fashion Color Report Fall 2012










